VolitionRx Limited to Present at Jefferies Global Healthcare Conference PR Newswire HENDERSON, Nevada, May 29, 2024 HENDERSON, Nevada , May 29, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that Cameron Reynolds , President and Group Chief Executive Officer, will present and be available for one-to-one meetings at the Jefferies Global Healthcare Conference in New York City . Presentation Details: Date: Wednesday,...